Efficacy of OsteoBor in Postmenopausal Osteoporosis
Status:
NOT_YET_RECRUITING
Trial end date:
2025-09-01
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the impact of boron supplementation (OsteoBor) on bone health in postmenopausal women. The trial is a phase 2, randomised, double-blind, placebo-controlled study lasting one year